News

New data show improved outcomes in resectable pancreatic cancer with PAXG chemotherapy over standard mFOLFIRINOX, but should ...
The global market for facial erythema treatments is projected to grow at a CAGR of 5% from 2025 to 2030, driven by several ...
Biotech firm Kymera Therapeutics announced strong results Monday, in the first human tests of a pill for autoimmune ailments like dermatitis and asthma. Its drug seems about a year ahead of other ...
Vice president and general manager of UK & Ireland at LEO Pharma, Sarah Kleinpeter, said: “We are pleased that adolescents between 12-17 years of age living with atopic dermatitis will now have ...
Just a few months after buying Timber Pharma, LEO Pharma has revealed that the main drug it acquired as part of the deal has failed a phase 3 trial. Timber's lead candidate TMB-001 for rare skin ...
Delgocitinib cream is more effective and has a better safety profile than oral alitretinoin for the treatment of severe chronic hand eczema.
Global virtual clinical trials market is estimated close to $8 billion (2020) and is growing above 10% CAGR. The market growth is driven by growing adoption of virtual trials following outbreak of ...
When it comes to the cut-throat world of high society, there are plenty of 'ordinary' women who have managed to hit the ...
Investment Week provides the latest investment news, analysis and opinion for wealth managers and the UK funds industry ...
The President has blamed the Federalist Society for “bad advice” on judicial nominations, after a court ruled against his ...
Pope Leo XIV appointed Monsignor Renzo Pegoraro as the leader of the church group Pontifical Academy for Life.
Pope Leo XIV visited the papal summer palace south of Rome on Thursday as questions swirled whether he will use it himself to ...